Search Results - "Wyrzucki, Arkadiusz M."
-
1
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
Published in Cell (14-10-2011)“…Chronic myelogenous leukemia (CML) is caused by the constitutively active tyrosine kinase Bcr-Abl and treated with the tyrosine kinase inhibitor (TKI)…”
Get full text
Journal Article -
2
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
Published in Cell (01-10-2011)Get full text
Journal Article